ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours

C. Coyle, Ruth E. Langley, Alistair Ring et al.|Contemporary Clinical Trials|2016

Cited by 162